Logo image of ALSPT.PA

SPARTOO (ALSPT.PA) Stock Fundamental Analysis

Europe - EPA:ALSPT - FR00140043Y1 - Common Stock

0.373 EUR
0 (-0.27%)
Last: 10/21/2025, 7:00:00 PM
Fundamental Rating

3

Overall ALSPT gets a fundamental rating of 3 out of 10. We evaluated ALSPT against 53 industry peers in the Specialty Retail industry. While ALSPT seems to be doing ok healthwise, there are quite some concerns on its profitability. ALSPT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALSPT had negative earnings in the past year.
In the past year ALSPT had a positive cash flow from operations.
In multiple years ALSPT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALSPT reported negative operating cash flow in multiple years.
ALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

ALSPT has a Return On Assets of -2.62%. This is comparable to the rest of the industry: ALSPT outperforms 41.51% of its industry peers.
The Return On Equity of ALSPT (-7.89%) is worse than 62.26% of its industry peers.
With a decent Return On Invested Capital value of 7.75%, ALSPT is doing good in the industry, outperforming 67.92% of the companies in the same industry.
Industry RankSector Rank
ROA -2.62%
ROE -7.89%
ROIC 7.75%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPT.PA Yearly ROA, ROE, ROICALSPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

ALSPT has a Operating Margin (3.72%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ALSPT has grown nicely.
ALSPT has a Gross Margin of 50.88%. This is in the better half of the industry: ALSPT outperforms 73.58% of its industry peers.
ALSPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.72%
PM (TTM) N/A
GM 50.88%
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
ALSPT.PA Yearly Profit, Operating, Gross MarginsALSPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALSPT is still creating some value.
Compared to 1 year ago, ALSPT has more shares outstanding
ALSPT has a better debt/assets ratio than last year.
ALSPT.PA Yearly Shares OutstandingALSPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ALSPT.PA Yearly Total Debt VS Total AssetsALSPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ALSPT has an Altman-Z score of 1.69. This is a bad value and indicates that ALSPT is not financially healthy and even has some risk of bankruptcy.
ALSPT has a Altman-Z score (1.69) which is in line with its industry peers.
The Debt to FCF ratio of ALSPT is 3.41, which is a good value as it means it would take ALSPT, 3.41 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALSPT (3.41) is better than 77.36% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that ALSPT is somewhat dependend on debt financing.
The Debt to Equity ratio of ALSPT (0.50) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.41
Altman-Z 1.69
ROIC/WACC1.33
WACC5.82%
ALSPT.PA Yearly LT Debt VS Equity VS FCFALSPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

ALSPT has a Current Ratio of 1.83. This is a normal value and indicates that ALSPT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.83, ALSPT belongs to the top of the industry, outperforming 81.13% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that ALSPT may have some problems paying its short term obligations.
ALSPT's Quick ratio of 0.70 is in line compared to the rest of the industry. ALSPT outperforms 52.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 0.7
ALSPT.PA Yearly Current Assets VS Current LiabilitesALSPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALSPT have decreased strongly by -24.17% in the last year.
ALSPT shows a decrease in Revenue. In the last year, the revenue decreased by -8.71%.
Measured over the past years, ALSPT shows a decrease in Revenue. The Revenue has been decreasing by -4.60% on average per year.
EPS 1Y (TTM)-24.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1334.69%
Revenue 1Y (TTM)-8.71%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-6.86%

3.2 Future

ALSPT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
The Revenue is expected to decrease by -2.10% on average over the next years.
EPS Next Y-150%
EPS Next 2Y73.21%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year-8.43%
Revenue Next 2Y-3.85%
Revenue Next 3Y-2.1%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSPT.PA Yearly Revenue VS EstimatesALSPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSPT.PA Yearly EPS VS EstimatesALSPT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPT. In the last year negative earnings were reported.
Also next year ALSPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPT.PA Price Earnings VS Forward Price EarningsALSPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALSPT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than ALSPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.12
EV/EBITDA 0.98
ALSPT.PA Per share dataALSPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3Y0%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSPT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPARTOO

EPA:ALSPT (10/21/2025, 7:00:00 PM)

0.373

0 (-0.27%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners35.75%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.82M
Analysts82
Price Target0.82 (119.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.88%
Revenue NY rev (3m)-3.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 1.12
P/OCF 1.04
P/B 0.23
P/tB 0.28
EV/EBITDA 0.98
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)0.33
FCFY89.46%
OCF(TTM)0.36
OCFY96.31%
SpS7.14
BVpS1.62
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -7.89%
ROCE 10.54%
ROIC 7.75%
ROICexc 11.61%
ROICexgc 13.8%
OM 3.72%
PM (TTM) N/A
GM 50.88%
FCFM 4.68%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y13.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y13.21%
ROICexc growth 5YN/A
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
F-Score3
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.41
Debt/EBITDA 1.18
Cap/Depr 6.11%
Cap/Sales 0.36%
Interest Coverage 250
Cash Conversion 52.52%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 0.7
Altman-Z 1.69
F-Score3
WACC5.82%
ROIC/WACC1.33
Cap/Depr(3y)16.79%
Cap/Depr(5y)31.52%
Cap/Sales(3y)0.76%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1334.69%
EPS Next Y-150%
EPS Next 2Y73.21%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.71%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-6.86%
Revenue Next Year-8.43%
Revenue Next 2Y-3.85%
Revenue Next 3Y-2.1%
Revenue Next 5YN/A
EBIT growth 1Y59.21%
EBIT growth 3Y20.46%
EBIT growth 5YN/A
EBIT Next Year315.84%
EBIT Next 3Y72.78%
EBIT Next 5YN/A
FCF growth 1Y84.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.49%
OCF growth 3YN/A
OCF growth 5YN/A